FDA Approved: SUMATRIPTAN — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s generic Sumatriptan under an Original Application (ANDA) for the treatment of acute migraine. This marks the approval of a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)